Small conclusion with facts, reflections and quest
Post# of 288
(Total Views: 336)
Posted On: 02/24/2018 8:26:34 AM
Small conclusion with facts, reflections and questions about this stock uptil today;
https://docs.wixstatic.com/ugd/1943b6_9a2f1cc...545fad.pdf is latest quarterly report of the QBL status (summary).
See; https://www.queenslandbauxite.com/ for latest news with all incl.
Australian stocks undervalued compared to peers in USA; questions to adress when investing outside US and Canada stock-exchanges. Minus with smaller domestic market, plus with often more value and higher leverage.
How to proceed in the short, mid and long run; the finance of each part of the company. Shareholders in JV and the deals made of common interest - different future scenarios risks and opportunity.
Evaluate the businessmodel to see where they are going now, in a year or within 3-5 year ? IP-value of patents etc - the people and the products; Long term business experience, well-connected in both Australia, US and Canada; strong position with first takeover bid raise further attention within the industry.
North-american chemist team to work on new applications/products.
Within 4 months the canadian cannabis market go boom, California get hit hard on strict cannabis permits not in place, GMP-certification is a must for the pharma/medical approval.
The fragmented industry (cannabis/hemp) gets more M&A each day.
How the QBL will profit is a question, but not IF they will profit - my guess is sooner or later there MCL-division will be sold to a major player in US or Canada.
Meanwhile, the approval in Australia can go quick, with that opens a door also to the gigantic Asian market (59% of global population). Next month will be exciting; the approval process starts and the products will be ready to launch to the market.
https://docs.wixstatic.com/ugd/1943b6_9a2f1cc...545fad.pdf is latest quarterly report of the QBL status (summary).
See; https://www.queenslandbauxite.com/ for latest news with all incl.
Australian stocks undervalued compared to peers in USA; questions to adress when investing outside US and Canada stock-exchanges. Minus with smaller domestic market, plus with often more value and higher leverage.
How to proceed in the short, mid and long run; the finance of each part of the company. Shareholders in JV and the deals made of common interest - different future scenarios risks and opportunity.
Evaluate the businessmodel to see where they are going now, in a year or within 3-5 year ? IP-value of patents etc - the people and the products; Long term business experience, well-connected in both Australia, US and Canada; strong position with first takeover bid raise further attention within the industry.
North-american chemist team to work on new applications/products.
Within 4 months the canadian cannabis market go boom, California get hit hard on strict cannabis permits not in place, GMP-certification is a must for the pharma/medical approval.
The fragmented industry (cannabis/hemp) gets more M&A each day.
How the QBL will profit is a question, but not IF they will profit - my guess is sooner or later there MCL-division will be sold to a major player in US or Canada.
Meanwhile, the approval in Australia can go quick, with that opens a door also to the gigantic Asian market (59% of global population). Next month will be exciting; the approval process starts and the products will be ready to launch to the market.
(0)
(0)
Robert